Catalysis can significantly enhance the efficiency of drug delivery systems. Prodrugs are inactive compounds that can be converted into active drugs through catalytic reactions within the body. Enzyme-responsive drug delivery systems utilize specific enzymes that are overexpressed in tumor tissues to trigger the release of the active drug, thereby minimizing side effects and improving therapeutic outcomes.
